Kezar Life Sciences, Inc. (KZR) Financial Statements (2026 and earlier)

Company Profile

Business Address 4000 SHORELINE COURT, SUITE 300
SOUTH SAN FRANCISCO, CA 94080
State of Incorp. DE
Fiscal Year End December 31
Industry (SIC) 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete Financial Analysis Financial Benchmarking

Balance Sheet (Statement of Financial Position) ($ in thousands)
Annual | Quarterly

3/31/2026
MRQ
12/31/2025
12/31/2024
12/31/2023
12/31/2022
12/31/2021
12/31/2020
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments71,878132,245201,372276,561208,355140,447
Cash and cash equivalent71,87841,74935,49340,45662,88221,228
Short-term investments  90,496165,879236,105145,473119,219
Receivables1,925424    
Prepaid expense6639259638,2412,5702,733
Asset, held-for-sale, not part of disposal group 520     
Other current assets    9207291,631
Other undisclosed current assets7463,8944,615   
Total current assets:75,732137,488206,950285,722211,654144,811
Noncurrent Assets
Operating lease, right-of-use asset7491,8864,7789,7412,7143,314
Property, plant, and equipment, after accumulated depreciation, depletion, and amortization 1662,8933,9123,4313,2833,435
Other noncurrent assets  2,4155,595674282282
Total noncurrent assets:9157,19414,28513,8466,2797,031
TOTAL ASSETS:76,647144,682221,235299,568217,933151,842
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities4,24811,58614,7328,4327,0135,379
Accounts payable5073,6518,2512,4792,0282,358
Accrued liabilities3,7417,9356,4815,9534,9853,021
Debt  5,217    
Other liabilities      21
Other undisclosed current liabilities2,3263,5263,0122,5651,1991,042
Total current liabilities:6,57420,32917,74410,9978,2126,442
Noncurrent Liabilities
Long-term debt and lease obligation  5,11110,0699,83412,8454,422
Long-term debt, excluding current maturities  5,11110,0699,8349,622 
Liabilities, other than long-term debt  2,3265,8528,865  
Operating lease, liability  2,3265,8528,8653,2234,422
Other undisclosed noncurrent liabilities     (3,223)(4,422)
Total noncurrent liabilities:  7,43715,92118,69912,8454,422
Total liabilities:6,57427,76633,66529,69621,05710,864
Equity
Equity, attributable to parent70,073116,916187,570269,872196,876140,978
Common stock7773685646
Additional paid in capital560,598551,570538,390519,620377,765267,093
Accumulated other comprehensive loss  (162)(130)(923)(291)(137)
Accumulated deficit(490,532)(434,499)(350,763)(248,893)(180,654)(126,024)
Total equity:70,073116,916187,570269,872196,876140,978
TOTAL LIABILITIES AND EQUITY:76,647144,682221,235299,568217,933151,842

Income Statement (P&L) ($ in thousands)
Annual | Quarterly

3/31/2026
TTM
12/31/2025
12/31/2024
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Revenues   7,000   
Gross profit:   7,000   
Operating expenses(59,107)(90,605)(118,424)(71,162)(54,659)(42,950)
Operating loss:(59,107)(90,605)(111,424)(71,162)(54,659)(42,950)
Nonoperating income
(Investment Income, Nonoperating)		4,4448,462    
Interest and debt expense(146)(1,593)(1,550)(1,185)(159) 
Other undisclosed loss from continuing operations before equity method investments, income taxes      
Loss from continuing operations before equity method investments, income taxes:(54,809)(83,736)(112,974)(72,347)(54,818)(42,950)
Other undisclosed loss from continuing operations before income taxes(1,224)     
Loss from continuing operations:(56,033)(83,736)(112,974)(72,347)(54,818)(42,950)
Loss before gain (loss) on sale of properties:✕✕✕✕✕(54,818)(42,950)
Other undisclosed net income   11,1044,1081881,208
Net loss:(56,033)(83,736)(101,870)(68,239)(54,630)(41,742)
Other undisclosed net income attributable to parent      
Net loss available to common stockholders, diluted:(56,033)(83,736)(101,870)(68,239)(54,630)(41,742)

Comprehensive Income ($ in thousands)
Annual | Quarterly

3/31/2026
TTM
12/31/2025
12/31/2024
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Net loss:(56,033)(83,736)(101,870)(68,239)(54,630)(41,742)
Comprehensive loss:(56,033)(83,736)(101,870)(68,239)(54,630)(41,742)
Other undisclosed comprehensive income (loss), net of tax, attributable to parent162(32)793(632)(154)59
Comprehensive loss, net of tax, attributable to parent:(55,871)(83,768)(101,077)(68,871)(54,784)(41,683)

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: